Empiric, broad-spectrum antibiotic therapy with an aggressive de-escalation strategy does not induce gram-negative pathogen resistance in ventilator-associated pneumonia

Surgical Infections

Volumn 11, Issue 5, 2010, Pages 427-432

  Hibbard, Michael L ^a   Kopelman, Tammy R ^a   O'Neill, Patrick J ^a   Maly, Tyler J ^a   Matthews, Marc R ^a   Cox, Jordy C ^a   Vail, Sydney J ^a   Quan, Asia N ^a   Drachman, David A ^a  

^a MARICOPA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CILASTATIN PLUS IMIPENEM; LEVOFLOXACIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; HUMAN; INTENSIVE CARE UNIT; LUNG LAVAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CILASTATIN; DRUG COMBINATIONS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PNEUMONIA, VENTILATOR-ASSOCIATED; RETROSPECTIVE STUDIES; TOBRAMYCIN;

EID: 77957586321     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2009.046     Document Type: Article

References (22)

1. Craven DE, Kunches LM, Kilinsky V, et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986;133:792-796.
2. Tablan OC, Anderson LJ, Besser R, et al. Guidelines for preventing health-care-associated pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53:1-36.
3. Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
4. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
5. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115-2121.
6. Clec'h C, Timsit JF, de Lassence A, et al. Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: Influence of disease severity. Intensive Care Med 2004;30:1327-1333.
7. Teixeira PJ, Seligman R, Hertz FT, et al. Inadequate treatment of ventilator-associated pneumonia: Risk factors and impact on outcomes. J Hosp Infect 2007;65:361-367.
8. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:281-288.
9. Fagon JY, Chastre J. Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients. Eur Respir J Suppl 2003;42:77s-83s.
10. Kopelman TR. Can empiric broad-spectrum antibiotics for ventilator-associated pneumonia be narrowed based on Gram's stain results of bronchoalveolar lavage fluid? Am J Surg 2006;192:812-816.
11. Meduri GU, Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest 1992;102:557S-564S.
12. Mylotte JM. Nursing home-acquired pneumonia. Clin Infect Dis 2002;35:1205-1211.
13. Hutt E, Kramer AM. Evidence-based guidelines for management of nursing home-acquired pneumonia. J Fam Pract 2002;51:709-716.
14. Siegel RE. Emerging gram-negative antibiotic resistance: Daunting challenges, declining sensitivities, and dire consequences. Respir Care 2008;53:471-479.
15. Lancaster JW, Lawrence KR, Fong JJ, et al. Impact of an institution-specific hospital-acquired pneumonia protocol on the appropriateness of antibiotic therapy and patient outcomes. Pharmacotherapy 2008;28:852-862.
16. Gaynes RP, Culver DH. Resistance to imipenem among selected gram-negative bacilli in the United States. Infect Control Hosp Epidemiol 1992;13:10-14.
17. Le Floch R, Arnould JF, Pilorget A. Effect of systematic empiric treatment with imipenem on the bacterial ecology in a burns unit. Burns 2005;31:866-869.
18. Namias N, Harvill S, Ball S, et al. Empiric therapy of sepsis in the surgical intensive care unit with broad-spectrum antibiotics for 72 hours does not lead to the emergence of resistant bacteria. J Trauma 1998;45:887-891.
19. Soo Hoo GW, Wen YE, Nguyen TV, Goetz MB. Impact of clinical guidelines in the management of severe hospitalacquired pneumonia. Chest 2005;128:2778-2787.
20. Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006;129:1210-1218.
21. Alvarez-Lerma F, Alvarez B, Luque P, et al. Empiric broadspectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: A prospective observational study. Crit Care 2006;10: R78.
22. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-417.